In This Article:
Intuitive Surgical ISRG recently announced that it has received FDA clearance for the first stapler specifically designed for use with single-port (SP) robotic surgical systems. The SureForm 45 stapler is engineered to work with the da Vinci SP platform, expanding the capabilities of minimally invasive procedures in narrow surgical spaces and enabling greater precision and access for surgeons.
This regulatory milestone marks a significant advancement in Intuitive Surgical’s innovation journey and reinforces its leadership in robotic-assisted surgery. The stapler’s curved-tip design, along with advanced smart features and robotic articulation, is expected to enhance surgical performance, improve patient outcomes, and broaden the range of procedures that can be performed using single-port technology.
Likely Trend of ISRG Stock Following the News
Following the announcement, shares of the company closed flat at $493.60 on Friday. In the year-to-date period, ISRG shares have lost 5.4% compared with the industry’s 12.5% decline. The S&P 500 decreased 9.1% in the same time frame.
However, the FDA clearance of Intuitive Surgical’s SureForm 45 stapler for SP robotic systems positions the company to further solidify its dominance in the robotic-assisted surgery market. By expanding the functionality of the da Vinci SP platform, Intuitive Surgical can drive increased adoption among hospitals and surgical centers seeking to offer more advanced, minimally invasive procedures. This could translate into higher recurring revenue from instrument and accessory sales, greater utilization of existing surgical systems, and a stronger competitive moat.
Meanwhile, ISRG currently has a market capitalization of $175.81 billion. ISRG’s earnings have surpassed its estimates for all the trailing four quarters, delivering an average surprise of 14.9%.
Image Source: Zacks Investment Research
More on ISRG’s SP SureForm 45 Stapler
Designed for thoracic, colorectal, and urologic procedures, the SP SureForm 45 is the first fully wristed stapler developed specifically for single-port robotic platforms. Its integration enables surgeons to perform complex stapling maneuvers through a single incision, reducing the invasiveness of procedures while maintaining high surgical precision and control. This evolution is significant in advancing minimally invasive surgery, particularly in anatomically restricted spaces where access is a challenge.
The SP SureForm 45 incorporates SmartFire technology, a key differentiator that enhances surgical safety and consistency. This proprietary system continuously monitors tissue compression before and during the stapling process, optimizing firing to maintain staple line integrity and minimize tissue trauma across variable tissue thicknesses. By providing surgeons with the ability to control stapling from the da Vinci SP console rather than relying on a bedside assistant, this stapler improves workflow efficiency and reduces operating time. Its wristed articulation further expands the range of surgical motions, enabling more natural and flexible instrument movement within confined anatomical zones.